Split History
ETFs Holding AGLE »    AGLE Historical Stock Prices »

Video: What is a Stock Split?

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Aeglea BioTherapeutics is a holding company. Through its subsidiaries, Co. is a biotechnology company developing human enzyme therapeutics for people with rare metabolic diseases. Co.'s development programs include: Pegzilarginase in Arginase 1 Deficiency, which is a recombinant human Arginase 1 that enzymatically degrades the amino acid arginine and improves the stability and arginine-degrading activity of the enzyme in human plasma; and AGLE-177 in Homocystinuria, which is a PEGylated, or polyethylene glycol modified, human enzyme engineered to degrade free homocysteine and homocystine. Co.'s preclinical pipeline includes cystinuria program to reduce plasma cystine and cysteine levels. According to our AGLE split history records, AGLE has had 1 split.
AGLE split history picture
AGLE (AGLE) has 1 split in our AGLE split history database. The split for AGLE took place on September 08, 2023. This was a 1 for 25 reverse split, meaning for each 25 shares of AGLE owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 40 share position following the split.

When a company such as AGLE conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.

Looking at the AGLE split history from start to finish, an original position size of 1000 shares would have turned into 40 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into AGLE shares, starting with a $10,000 purchase of AGLE, presented on a split-history-adjusted basis factoring in the complete AGLE split history. AGLE split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 04/08/2016
End date: 11/27/2023
Start price/share: $299.75
End price/share: $12.01
Dividends collected/share: $0.00
Total return: -95.99%
Average Annual Total Return: -34.36%
Starting investment: $10,000.00
Ending investment: $400.84
Years: 7.64
Date Ratio
09/08/20231 for 25
AGLE is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

AGN Split History
AGRX Split History
AHPI Split History
AIMT Split History
AIQ Split History
AIRM Split History
AKER Split History
ALBO Split History
ALC Split History
ALIM Split History

Also explore: AGLE shares outstanding history

Email EnvelopeFree AGLE Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

OpGen, Inc. (OPGN)
Blue Star Foods Corp. (BSFC)
Charles & Colvard, Ltd. (CTHR)
Seelos Therapeutics, Inc. (SEEL)
Chimera Investment Corporation (CIM)
Advent Technologies Holdings, Inc. (ADN)
Telesis Bio Inc. (TBIO)
United States Lime & Minerals, Inc. (USLM)
Inspire Veterinary Partners, Inc. (IVP)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

AGLE Insider Buying

AGLE Split History | www.SplitHistory.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
Wait! Don't leave yet.
Want to receive our latest research absolutely free?

Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.